alexa Chemical Genomics Of Plasmodium Falciparum From Hemozoin And Parasite Inhibition Profiles Of Approved Drugs
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Hematology & Blood Disorders
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

David J Sullivan
ScientificTracks Abstracts: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.006
Abstract
When the Plasmodium parasite invades human erythrocytes, it catabolizes the host?s hemoglobin in an acidic digestive vacuole, which releases toxic heme. To protect itself from oxidative damage, the parasite initiates the crystallization of heme into harmless hemozoin, the malarial pigment. Many classes of drugs including the widely used antimalarial quinolines have been found to inhibit this process We have probed a library of more than 1,500 FDA approved drugs for heme crystal and whole cell/infected Plasmodium falciparum inhibition for liver, asexual erythrocyte and sexual gametocyte stages. We found both class effects and also unique inhibition of individual drugs amongst a drug class. A few drugs were able to inhibit liver or gametocyte stages as well. Vulnerable Plasmodium metabolic pathways can be targeted by fungal azoles, many antidepressants and antipsychotics, HIV aspartic protease inhibitors, calcium channel blockers, kinase inhibitors and antihistamines. A comparison of hemozoin inhibition to erythrocyte inhibitioncomparisons reveals that many strong hemozoin inhibitors actually have minimal effect on the parasite itself, because not all drugs that inhibit hemozoin are able to accumulate at the target site. Novel malaria drugs, which inhibit both the parasite and hemozoin were found in many diverse therapeutic drug classes. Interestingly two antimalarial quinolines have irreversible heme crystal inhibition. The screens to find new uses for existing drugs can elucidate novel pathways for drug targets as well as improve existing malaria targets.
Biography
David J Sullivan completed his MD at the University of Alabama at Birmingham and trained in Internal Medicine and Infectious Diseases at Washington University/ Barnes Hospital. He is an Associate Professor at the Johns Hopkins Malaria Research Institute. His research work communicated in over 100 publications has explored mechanisms of quinoline action and resistance related to hemozoin formation in Plasmodium , developed novel malaria diagnostic techniques, contributed to understanding of pathogenesis of disease, initiated ongoing malaria epidemiologic studies in Bangladesh and contributed an evidence base for new uses of existing drugs.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords